Vikram Purohit analyst MORGAN STANLEY

Currently out of the existing stock ratings of Vikram Purohit, 55 are a BUY (42.97%), 70 are a HOLD (54.69%), 3 are a SELL (2.34%).

Vikram Purohit

Work Performance Price Targets & Ratings Chart

Analyst Vikram Purohit, currently employed at MORGAN STANLEY, carries an average stock price target met ratio of 41.84% that have a potential upside of 44.57% achieved within 117 days.

Vikram Purohit’s has documented 298 price targets and ratings displayed on 20 stocks. The coverage is on the Healthcare sector.

Most recent stock forecast was given on ASND, Ascendis Pharma AS at 16-May-2024.

Wall Street Analyst Vikram Purohit

Analyst best performing recommendations are on ARQT (ARCUTIS BIOTHERAPEUTICS ).
The best stock recommendation documented was for ARQT (ARCUTIS BIOTHERAPEUTICS ) at 12/21/2023. The price target of $11 was fulfilled within 71 days with a profit of $8.4 (323.08%) receiving and performance score of 45.5.

Average potential price target upside

AXSM Axsome Therapeutics CERT Certara FHTX Foghorn Therapeutics  HOOK Hookipa Pharma INCY yte KYMR Kymera Therapeutics RDUS Schnitzer Steel Industries SAGE Sage Therapeutic TALS Talaris Therapeutics TBPH Theravance Biopharma EVLO Evelo Biosciences EXAI Exscientia Ltd ADR TIL Instil Bio . RGNX Regenxbio SDGR Schrodinger ARQT Arcutis Biotherapeutics  ASND Ascendis Pharma AS AKLI Akili HALO Halozyme Therapeutics BMRN Biomarin Pharmaceutical

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Buy

106

$23.17 (27.97%)

106

1 months 2 days ago

8/16 (50%)

$34.45 (48.15%)

148

Buy

190

$107.17 (129.39%)

190

1 months 8 days ago

6/26 (23.08%)

$115.24 (154.15%)

108

Hold

115

$32.17 (38.84%)

90

2 months 15 days ago

14/19 (73.68%)

$43.29 (60.37%)

58

Buy

125

$42.17 (50.91%)

110

4 months 23 days ago

5/10 (50%)

$42.89 (52.23%)

82

Buy

108

$25.17 (30.39%)

108

4 months 24 days ago

7/15 (46.67%)

$26.86 (33.10%)

49

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

Which stock is Vikram Purohit is most bullish on?

Potential upside of $32.17 has been obtained for AXSM (AXSOME THERAPEUTICS)

Which stock is Vikram Purohit is most reserved on?

Potential downside of $1.31 has been obtained for EXAI (EXSCIENTIA LTD ADR)

What Year was the first public recommendation made by Vikram Purohit?

On 2016

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?